DRG Team |
Managing Director
Michael Schröder
|
Michael Schröder serves as the Managing Director of DRG Instruments GmbH, overseeing both the strategic direction and day-to-day operations of the company. He is committed to a values-driven leadership approach, emphasizing quality, efficiency, and the sustainable development of employees and processes within a highly regulated industrial environment. |
![]() |
Head of Research and Development
Dipl.-Ing. (FH) Thomas Zeller
Thomas Zeller is Head of Research & Development at DRG Instruments GmbH in Marburg, Germany.
In 2011, Thomas Zeller joined DRG as R&D Senior Scientist and Project Manager. In this role, he was responsible for the development, optimization and validation of diagnostic assays for manual and automated platforms, while coordinating complex R&D projects and supporting regulatory and quality-related activities. He has successfully led numerous product development projects from concept to market launch and has contributed significantly to the company's innovation and growth.
Since 2026, Thomas Zeller has been Head of Research & Development, leading strategic R&D initiatives, product development, and collaboration with internal and external stakeholders. Leveraging his extensive scientific and industry expertise, he drives the development of innovative diagnostic solutions and supports the continued success of the DRG Group.
Head of QM/QA
Dr. Hero Brahms
Dr. Hero Brahms is the Head of QM/QA.
In 2002, Dr. Brahms joined the DRG Group as a Developer in the German facility. An integral part of the research and development team of DRG Instruments, he was involved in the development and validation of new ELISAs. Along with his work in research and development, he is the Medical Security Manager of DRG Instruments.
Earlier in his career, Dr. Brahms worked in the field of Oligonucleotide synthesis at the Max-Planck-Institute for Experimental Medicine in Göttingen, Germany.
Dr. Brahms performed research as a postdoctoral scientist, both in immunology and molecular biology. His work on the role of posttranslational modifications in autoimmune diseases and cell biology at the Max-Planck-Institute for Biophysical Chemistry was awarded with the RPI/ RNA award for young scientists by the RNA Society, which is dedicated to the study of Ribonucleic Acid.
Head of Production
Mr. René Linke
Project Management DRG:HYBRiD-XL
Mr. Marco Euler
Product Management ELISA / DRG:HYBRiD-XL
Ms. Julia Räder
Product Management Infectious Diseases / Autoimmunity / DxDATATM
Ms. Stefanie Lamers
Vice President of Sales Western & Central Europe
Mr. Andrey Krinitsyn
Order Processing Teamlead
Ms. Carolina Angulo Fiedler
Head of Warehouse
Mr. Philipp Wöstheinrich

